In a 7,12-dimethylbenz[a]anthracene (DMBA)-induced animal tumor model, fucoidan suppresses breast cancer cell-xenografted tumor growth by inhibiting PI3K/AKT/GSK3β signaling [138]. The gene discussed is AKT1; the disease is breast carcinoma.